Testing a Scalable Model of Care to Improve Patients Access to Mental Health Services After Traumatic Injury
Launched by MEDICAL UNIVERSITY OF SOUTH CAROLINA · Aug 9, 2022
Trial Information
Current as of October 15, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a program called the Trauma Resilience and Recovery Program (TRRP), which aims to help patients who have experienced traumatic injuries and may be struggling with conditions like posttraumatic stress disorder (PTSD) or depression. The study wants to understand how patients feel about this program and an enhanced care group that works alongside it. If you or a loved one is 16 years old or older, speaks English or Spanish, and has been admitted to the trauma center at George Washington University hospital with signs of PTSD or depression, you might be eligible to participate.
Participants in this study can expect to share their experiences with the TRRP and receive support aimed at improving their mental health after a traumatic event. However, individuals with severe cognitive issues, active psychosis, or certain types of injuries that affect communication will not be included. This is an important step in making sure that patients receive the right type of care for their needs. If you think this trial might be a fit for you or someone you know, consider talking to your healthcare provider for more information.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • English- or Spanish-speaking patients ≥ 16 years old who are admitted to George Washington University hospital's trauma center and screen positive on the Injured Trauma Survivors Screen (which indicates risk for development of posttraumatic stress disorder and/or depression) will be included.
- Exclusion Criteria:
- • Patients who have a Glasgow Coma Scale score under 13 at hospital admission, moderate to severe cognitive impairment (as measured by the Montreal Cognitive Assessment), active psychosis, or injury that prevents verbal communication (e.g., serious head or spinal cord injury) or is self-inflicted will be excluded. Patients with positive substance use screens via GWU's SBIRT protocol (\~7% of the patient population) will be assessed by the clinical team with reference to severity and recency of substance use problems. We have found at MUSC that a high percentage of patients with SBIRT- positive screens are nevertheless good candidates for TRRP (\>85%), but patients with serious, active substance abuse problems are likely not good candidates for TRRP and therefore will be excluded and referred to a substance use treatment center.
About Medical University Of South Carolina
The Medical University of South Carolina (MUSC) is a leading academic health center dedicated to advancing medical research and improving patient care through innovative clinical trials. With a strong emphasis on translational medicine, MUSC leverages its extensive resources and expertise to facilitate groundbreaking studies across various medical disciplines. The institution is committed to fostering collaboration among researchers, healthcare professionals, and patients, ensuring that cutting-edge discoveries translate into effective treatments. As a pioneer in health education and research, MUSC plays a vital role in shaping the future of medicine and enhancing health outcomes in the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Washington, Virginia, United States
Patients applied
Trial Officials
Kenneth Ruggiero, PhD
Principal Investigator
Medical University of South Carolina
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials